"10.1371_journal.pone.0125593","plos one","2015-05-07T00:00:00Z","David J Sullivan; Yi Liu; Bryan T Mott; Nikola Kaludov; Martin N Martinov","W. Harry Feinstone Department of Molecular Micorbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, United States of America; Gradient Biomodeling LLC, Park City, Utah, United States of America","Conceived and designed the experiments: DJS NK MNM. Performed the experiments: YL BTM DJS NK MNM. Analyzed the data: YL BTM DJS NK MNM. Contributed reagents/materials/analysis tools: YL BTM DJS NK MNM. Wrote the paper: YL BTM DJS NK MNM.","David Sullivan, Yi Liu, Nick Kaludov, Martin N. Martinov, the Johns Hopkins University and Gradient Biomodeling LLC have filed for intellectual property protection on the development of Centhromycin as malaria prevention/eradication therapy. Pending patent name is “Macrolide for liver stage malaria” and number is “EFS ID 19956911”. Nikola Kaludov and Martin N. Martinov were affiliated with Gradient Biomodeling LLC at the time of the research. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.","2015","05","David J Sullivan","DJS",5,TRUE,3,5,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
